WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Securities Hematology and Oncology Summit, taking place virtually on December 2, 2024. On Monday, December 2, at 11:30 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat. A live ...

Core Viewpoint - Marker Therapeutics, Inc. is set to present its technology and clinical developments at the Citizens JMP Hematology and Oncology Summit on December 2, 2024, highlighting its focus on next-generation T cell-based immunotherapies for hematological malignancies and solid tumors [1][2]. Company Overview - Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company based in Houston, TX, specializing in developing T cell-based immunotherapies for treating hematological malignancies and solid tumors [5]. - The company has conducted clinical trials involving over 200 patients, demonstrating that its autologous and allogeneic multiTAA-specific T cell products are well tolerated and show durable clinical responses [5]. - Marker aims to introduce novel T cell therapies to the market to improve patient outcomes while prioritizing financial resource preservation and operational excellence [5]. - The company benefits from non-dilutive funding from U.S. state and federal agencies that support cancer research, strengthening its unique T cell platform [5]. Event Details - Dr. Juan Vera, President and CEO of Marker Therapeutics, will present at the Citizens JMP Hematology and Oncology Summit on December 2, 2024, at 11 AM EST [2][3]. - The event will be held virtually, and a replay of Dr. Vera's presentation will be available on the company's Investor Relations website [3]. - During the conference, Dr. Vera and the Marker management team will conduct one-on-one meetings with registered investors to showcase the company's business and clinical development [4].

The debt warehouse facility and structured equity investment will support construction of 300 Megawatts of U.S. community solar projects and is Pivot's largest financing agreement to dateDENVER, Nov. 21, 2024 /PRNewswire/ -- Pivot Energy ("Pivot"), a leading, national renewable energy provider and independent power producer, announced today two transformational financing arrangements, marking a critical step toward establishing innovative and scalable financing facilities. Pivot has successfully secured a $ ...

Austin, Texas--(Newsfile Corp. - November 7, 2024) - Citizens, Inc. (NYSE: CIA), a leading diversified financial services company specializing in life, living benefits and final expense insurance, today reported results for the third quarter ended September 30, 2024."We are thrilled to report strong sales momentum and exceptional execution in the third quarter and throughout 2024 with several significant developments. Our strategic roadmap is designed to deliver improved operating results and sustainable g ...

Core Insights - First Citizens BancShares, Inc. (FCNCA) experienced a significant Power Inflow, indicating a potential uptrend in its stock price, which closed at $2,272.61, up 18.27% on the day [1][2]. Trading Signals - A Power Inflow was recorded at a price of $2,171.52, suggesting a bullish sentiment among traders and a possible entry point for capitalizing on upward movement [2][4]. - The stock's high price reached $2,275.90, with returns of 4.8% and 4.4% from the high and close prices after the Power Inflow, respectively [6]. Order Flow Analytics - Order flow analytics, which analyze the volume of buy and sell orders, are crucial for understanding market conditions and making informed trading decisions [3][5]. - The Power Inflow typically occurs within the first two hours of market opening and is driven by institutional activity, helping to gauge the stock's overall direction for the day [4].

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- First Citizens Bank today announced that its Energy Finance business is introducing a new tax equity investment product to help finance renewable energy projects. Tax equity products enable qualified investors to reap the benefits of various tax incentives aimed at promoting the development of renewable energy. As an industry leader in renewable energy financing, First Citizens Energy Finance is well positioned to expand its product capabilities, which will now includ ...

Economist with 10-year experience doing sell-side research on euro-area and emerging market economies. My credo is that doing your homework is essential when investing and seeing as many viewpoints as possible can only help you make better investment decisions. I hope I can do my part to guide you through the markets!I have passed the CFA Level 3 exam. I have a Bachelor's Degree in Economics. Disclaimer: I DO NOT provide financial advice. All opinions expressed on financial instruments are my own and may no ...

EAU CLAIRE, Wis., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Citizens Community Bancorp, Inc. (the "Company") (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the "Bank" or "CCFBank"), today reported earnings of $3.3 million and earnings per diluted share of $0.32 for the third quarter ended September 30, 2024, compared to $3.7 million and earnings per diluted share of $0.35 for the quarter ended June 30, 2024, and $2.5 million and $0.24 earnings per diluted share for the quarter ended Septembe ...

Group 1 - BD (Becton, Dickinson and Company) has been recognized as one of the 100 Best Corporate Citizens of 2024, ranking second in the health care equipment and services industry for the second consecutive year [1][3] - The 100 Best Corporate Citizens list evaluates over 1,000 of the largest U.S. public companies based on more than 200 factors across seven pillars, including climate change, employee relations, and governance [3][5] - Tom Polen, CEO of BD, emphasized that corporate sustainability is integral to the company's business strategy and is essential for making responsible decisions that impact global health care [3] Group 2 - BD is one of the largest global medical technology companies, focusing on improving medical discovery, diagnostics, and care delivery [4] - The company employs approximately 77,000 individuals and is committed to enhancing the safety and efficiency of health care delivery processes [4] - BD collaborates with organizations worldwide to tackle significant global health challenges, aiming to improve outcomes, reduce costs, and expand access to health care [4]

RALEIGH, N.C., Oct. 24, 2024 /PRNewswire/ -- First Citizens BancShares, Inc. ("BancShares") (Nasdaq: FCNCA) reported earnings for the third quarter of 2024.Chairman and CEO Frank B. Holding, Jr. said: "We posted another quarter of strong financial results, largely in line with our expectations. Loan growth remained resilient in both the General Bank and Commercial Bank segments, while loans in the SVB Commercial segment declined as Global Fund Banking repayment levels outpaced draw activity. We experienced ...